The Latest Breaking News from Tobacco

Biden's FDA pushed a prohibition that disproportionately targeted marginalized communities. Trump's reversal may mark a shift toward smarter drug policy.

The FDA has recently authorized the sale of Zyn nicotine pouches, marking a pivotal moment in tobacco harm reduction. As concerns about traditional smoking persist, nicotine pouches present a viable alternative for adult smokers. This approval underscores their potential public health benefits, despite challenges surrounding youth appeal.

Smoking and tobacco use continue to be significant health risks, contributing to a variety of diseases and conditions. There is a lot of evidence that smoking is bad for you, from lung cancer to heart disease. Even though there is a lot of proof to ...

Plus: TikTok bans, weak cigarettes, and more...

Police allege a man assaulted and threatened a tobacconist store owner before throwing an explosive device into the shop.

The acclaimed American filmmaker David Lynch has died at the age of 78. While a cause of death has yet to be publicly announced, Lynch, a lifelong tobacco enthusiast, revealed in 2024 he was suffering from emphysema.

Mandating negligible nicotine levels in tobacco products would create a big black market and criminalize currently legal transactions.

Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn can help adult smokers cut back or quit cigarettes

The authorization means pouches can be marketed to adults 21 or older but doesn’t mean the products are “FDA approved.”